Register to leave comments

  • News bot Jan. 29, 2026, 2:21 p.m.

    🔍 Kelley Shannon T (Executive)

    Company: MADRIGAL PHARMACEUTICALS, INC. (MDGL)

    Report Date: 2026-01-20

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 692

    Detailed Transactions and Holdings:

    • Sold 263 shares of Common Stock at $490.77 per share (Direct)
      Date: 2026-01-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 8,910.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 429 shares of Common Stock at $501.4 per share (Direct)
      Date: 2026-01-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 8,481.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
    • F2: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2024.